Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 301.7 INR 2.24% Market Closed
Market Cap: 27.8B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+14%
Operating Income
Forecast
+26%
Net Income
Forecast
+27%

Wall Street
Price Targets

INDOCO Price Targets Summary
Indoco Remedies Ltd

Wall Street analysts forecast INDOCO stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INDOCO is 256.28 INR with a low forecast of 202 INR and a high forecast of 341.25 INR.

INDOCO Lowest Forecast
Wall Street Target
202 INR
33% Downside
INDOCO Average Forecast
Wall Street Target
256.28 INR
15% Downside
INDOCO Highest Forecast
Wall Street Target
341.25 INR
13% Upside
Lowest
Price Target
202 INR
33% Downside
Average
Price Target
256.28 INR
15% Downside
Highest
Price Target
341.25 INR
13% Upside
Indoco Remedies Ltd Competitors:
Price Targets
A
ABBOTINDIA
Abbott India Ltd
0% Upside
069620
Daewoong Pharma
42% Upside
M
600993
Mayinglong Pharmaceutical Group Co Ltd
35% Upside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
19% Upside
A
ABBOTINDIA
Abbott India Ltd
0% Upside
069620
Daewoong Pharma
42% Upside
M
600993
Mayinglong Pharmaceutical Group Co Ltd
35% Upside
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
19% Upside
4554
Fuji Pharma Co Ltd
55% Upside
K
4521
Kaken Pharmaceutical Co Ltd
23% Upside
ORMP
Oramed Pharmaceuticals Inc
54% Upside

Revenue
Forecast

Revenue Estimate
Indoco Remedies Ltd

For the last 13 years the compound annual growth rate for Indoco Remedies Ltd's revenue is 9%. The projected CAGR for the next 2 years is 16%.

9%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Indoco Remedies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Indoco Remedies Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

See Also

Summary
INDOCO intrinsic value, competitors valuation, and company profile.
DCF Valuation
INDOCO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INDOCO stock valuation using valuation multiples.
Wall Street Estimates
INDOCO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INDOCO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INDOCO's stock price target?
Price Target
256.28 INR

According to Wall Street analysts, the average 1-year price target for INDOCO is 256.28 INR with a low forecast of 202 INR and a high forecast of 341.25 INR.

What is Indoco Remedies Ltd's Revenue forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Indoco Remedies Ltd's revenue is 9%. The projected CAGR for the next 2 years is 16%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 264,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.